EUVIMEDEUVIMED entdecken
Open Access

FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis

Zhuoyao Wu iD, Weiwei Zeng, Weitao Yang iD, Jinyan Yi, Dinghua Liu, Yan Xu iD, Chang Liu, Kexin Bian iD, Hui Wang, Bingbo Zhang iD

Science Advances · 2025

DOI: 10.1126/sciadv.adt6082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Zhuoyao Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nan…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Liver Cirrhosis, Membrane Proteins, Serine Endopeptidases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is an inevitable stage in the progression of most chronic liver diseases. Early diagnosis and treatment of liver fibrosis are crucial for effectively managing chronic liver conditions. However, there lacks a noninvasive and sensitive imaging method capable of early assessing fibrosis activity. Here, we report a molecular magnetic resonance imaging (MRI) probe for imaging fibroblast activation protein (FAP), which is overexpressed on activated hepatic stellate cells (HSCs) even in very early fibrotic livers. This method relies on FAP-catalyzed in situ self-assembly of its substrate probe that leads to the increase of the rotational correlation time (τ R ) of probe, thereby notably amplifies T 1 MRI signal. Thanks to the superior specificity and efficiency of enzymatic reaction, our method has been validated as highly selective and sensitive to FAP in two liver fibrosis mouse models. By establishing a direct correlation between MRI signals and fibrosis activity, our method enables continuous monitoring of liver fibrotic disease progression and assessment of treatment responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingLiver CirrhosisMembrane ProteinsSerine EndopeptidasesGelatinasesAnimalsMiceHepatic Stellate CellsDisease Models, AnimalEndopeptidasesHumansMaleDisease ProgressionLiverFibroblast Activation Protein Alpha

Substanzen

Membrane ProteinsSerine EndopeptidasesGelatinasesEndopeptidasesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai 200065, Chi…

ORCID-Profile: Zhuoyao Wu, Weitao Yang, Yan Xu, Kexin Bian, Bingbo Zhang

Zitieren

APA

Wu, Z., Zeng, W., Yang, W., Yi, J., Liu, D., Xu, Y., Liu, C., Bian, K., Wang, H., & Zhang, B. (2025). FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis. Science Advances. https://doi.org/10.1126/sciadv.adt6082

Vancouver

Wu Z, Zeng W, Yang W, Yi J, Liu D, Xu Y, et al. FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis. Science Advances. 2025. doi:10.1126/sciadv.adt6082

BibTeX
@article{Wu2025,
  author = {Wu, Zhuoyao and Zeng, Weiwei and Yang, Weitao and Yi, Jinyan and Liu, Dinghua and Xu, Yan and Liu, Chang and Bian, Kexin and Wang, Hui and Zhang, Bingbo},
  title = {FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt6082}
}
Kostenlos starten →